Vivolight Medical Highlights Positive 355-nm Cold Laser Atherectomy Trial Findings as TCT 2026 Concludes
San Diego, California — November 3, 2026 — As Transcatheter Cardiovascular Therapeutics (TCT) 2026 draws to a close, Vivolight Medical is highlighting new randomized clinical trial findings showing that investigational 355-nm cold laser atherectomy (CLA) met its prespecified non-inferior...
Read More
English
Français
Español
Deutsch
Italiano
العربية
















IPv6 network supported